Kairos Pharma KAPA
NYSE KAPA
$0.29 -0.01 (-1.73%)
As of: Aug 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Selling, General & Administrative (2023 - 2025)

Kairos Pharma (KAPA) Selling, General & Administrative (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 Kairos Pharma 5.39 Mn 55,970.58 - -

Historic Data

Download Data
DateValue
Jun 30, 2025 960,000.00
Mar 31, 2025 773,000.00
Dec 31, 2024 1.27 Mn
Sep 30, 2024 369,000.00
Jun 30, 2024 159,000.00
Mar 31, 2024 122,000.00
Dec 31, 2023 1.08 Mn
Sep 30, 2023 254,000.00